Commercial Solutions in Life Sciences from a Data Perspective - with Jane Chen of Novartis

Today’s guest is Jane Chen, Director of Commercial Analytics for Women’s Cancer at Novartis. Jane joins us on the program today to highlight challenges in identifying and segmenting specific patient groups, particularly those with rare or niched diseases. Throughout the episode, she sheds a spotlight on privacy concerns in healthcare data, including blind spots due to HIPAA regulations. Later, she explains the ways healthcare leaders are testing the waters for generative AI applications in healthcare. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Om Podcasten

The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI. Each week, Emerj AI Research CEO Daniel Faggella and team interview top AI executives from Fortune 2000 firms and unicorn startups - uncovering trends, use-cases, and best practices for practical AI adoption. Visit our advertising page to learn more about reaching our executive audience of Fortune 2000 AI adopters: https://emerj.com/advertise